ARTICLE | Clinical News

Virulizin macrophage activator immunostimulant regulatory update

December 4, 2000 8:00 AM UTC

LOR received notice of allowance for a U.S. patent covering a method for the purification of Virulizin from bovine bile. The product is approved in Mexico to treat melanoma and is in Phase II testing ...